Tag: 4 Earnings miss

Browse exclusive Tags!

Biogen Stock Slumps as Q4 Earnings Miss Expectations, Aduhelm Costs Impact Profit

Biogen's stock slumps as Q4 earnings miss expectations and costs related to Aduhelm impact profit, raising concerns about the company's future prospects. A reminder of the challenges in the biotech industry.

Popular

Subscribe

spot_imgspot_img